vs

Side-by-side financial comparison of HEALTHY CHOICE WELLNESS CORP. (HCWC) and Sight Sciences, Inc. (SGHT). Click either name above to swap in a different company.

Sight Sciences, Inc. is the larger business by last-quarter revenue ($20.4M vs $18.7M, roughly 1.1× HEALTHY CHOICE WELLNESS CORP.). HEALTHY CHOICE WELLNESS CORP. runs the higher net margin — -8.9% vs -20.4%, a 11.5% gap on every dollar of revenue. HEALTHY CHOICE WELLNESS CORP. produced more free cash flow last quarter ($-927.1K vs $-2.0M).

Sight Sciences, Inc. is a commercial-stage medical technology company focused on developing and commercializing innovative products for treating common eye conditions including glaucoma and dry eye disease. It offers minimally invasive surgical devices and non-surgical care solutions, primarily serving ophthalmology clinicians and patients across the United States.

HCWC vs SGHT — Head-to-Head

Bigger by revenue
SGHT
SGHT
1.1× larger
SGHT
$20.4M
$18.7M
HCWC
Higher net margin
HCWC
HCWC
11.5% more per $
HCWC
-8.9%
-20.4%
SGHT
More free cash flow
HCWC
HCWC
$1.1M more FCF
HCWC
$-927.1K
$-2.0M
SGHT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCWC
HCWC
SGHT
SGHT
Revenue
$18.7M
$20.4M
Net Profit
$-1.7M
$-4.2M
Gross Margin
39.1%
87.3%
Operating Margin
-7.6%
-18.0%
Net Margin
-8.9%
-20.4%
Revenue YoY
6.9%
Net Profit YoY
64.9%
EPS (diluted)
$-0.05
$-0.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCWC
HCWC
SGHT
SGHT
Q4 25
$18.7M
$20.4M
Q3 25
$19.0M
$19.9M
Q2 25
$20.2M
$19.6M
Q1 25
$20.3M
$17.5M
Q4 24
$19.1M
Q3 24
$18.2M
$20.2M
Q2 24
$21.4M
Q1 24
$19.3M
Net Profit
HCWC
HCWC
SGHT
SGHT
Q4 25
$-1.7M
$-4.2M
Q3 25
$-1.2M
$-8.2M
Q2 25
$-339.4K
$-11.9M
Q1 25
$-712.4K
$-14.2M
Q4 24
$-11.8M
Q3 24
$-2.7M
$-11.1M
Q2 24
$-12.3M
Q1 24
$-16.3M
Gross Margin
HCWC
HCWC
SGHT
SGHT
Q4 25
39.1%
87.3%
Q3 25
38.8%
86.4%
Q2 25
40.1%
84.8%
Q1 25
38.8%
86.2%
Q4 24
86.8%
Q3 24
38.4%
83.9%
Q2 24
85.8%
Q1 24
85.5%
Operating Margin
HCWC
HCWC
SGHT
SGHT
Q4 25
-7.6%
-18.0%
Q3 25
-3.2%
-39.7%
Q2 25
-0.2%
-59.6%
Q1 25
-2.0%
-79.2%
Q4 24
-62.5%
Q3 24
-2.0%
-55.7%
Q2 24
-59.2%
Q1 24
-76.4%
Net Margin
HCWC
HCWC
SGHT
SGHT
Q4 25
-8.9%
-20.4%
Q3 25
-6.4%
-41.0%
Q2 25
-1.7%
-61.0%
Q1 25
-3.5%
-80.8%
Q4 24
-62.1%
Q3 24
-14.6%
-54.9%
Q2 24
-57.7%
Q1 24
-84.4%
EPS (diluted)
HCWC
HCWC
SGHT
SGHT
Q4 25
$-0.05
$-0.07
Q3 25
$-0.09
$-0.16
Q2 25
$-0.03
$-0.23
Q1 25
$-0.07
$-0.28
Q4 24
$-0.23
Q3 24
$-0.29
$-0.22
Q2 24
$-0.25
Q1 24
$-0.33

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCWC
HCWC
SGHT
SGHT
Cash + ST InvestmentsLiquidity on hand
$3.0M
$92.0M
Total DebtLower is stronger
$7.3M
$42.4M
Stockholders' EquityBook value
$7.3M
$63.9M
Total Assets
$33.5M
$115.3M
Debt / EquityLower = less leverage
1.00×
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCWC
HCWC
SGHT
SGHT
Q4 25
$3.0M
$92.0M
Q3 25
$3.0M
$92.4M
Q2 25
$4.7M
$101.5M
Q1 25
$1.8M
$108.8M
Q4 24
$120.4M
Q3 24
$1.8M
$118.6M
Q2 24
$118.2M
Q1 24
$127.3M
Total Debt
HCWC
HCWC
SGHT
SGHT
Q4 25
$7.3M
$42.4M
Q3 25
$8.5M
$42.4M
Q2 25
$9.7M
$42.4M
Q1 25
$10.6M
$42.4M
Q4 24
$40.0M
Q3 24
$11.6M
$37.1M
Q2 24
$35.0M
Q1 24
$35.0M
Stockholders' Equity
HCWC
HCWC
SGHT
SGHT
Q4 25
$7.3M
$63.9M
Q3 25
$5.9M
$64.3M
Q2 25
$5.8M
$70.0M
Q1 25
$2.1M
$77.6M
Q4 24
$87.5M
Q3 24
$2.9M
$95.0M
Q2 24
$101.6M
Q1 24
$109.2M
Total Assets
HCWC
HCWC
SGHT
SGHT
Q4 25
$33.5M
$115.3M
Q3 25
$33.7M
$116.3M
Q2 25
$36.4M
$122.0M
Q1 25
$34.1M
$129.7M
Q4 24
$142.8M
Q3 24
$33.2M
$143.6M
Q2 24
$149.7M
Q1 24
$155.6M
Debt / Equity
HCWC
HCWC
SGHT
SGHT
Q4 25
1.00×
0.66×
Q3 25
1.43×
0.66×
Q2 25
1.69×
0.61×
Q1 25
5.01×
0.55×
Q4 24
0.46×
Q3 24
3.95×
0.39×
Q2 24
0.34×
Q1 24
0.32×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCWC
HCWC
SGHT
SGHT
Operating Cash FlowLast quarter
$-855.1K
$-1.8M
Free Cash FlowOCF − Capex
$-927.1K
$-2.0M
FCF MarginFCF / Revenue
-5.0%
-9.7%
Capex IntensityCapex / Revenue
0.4%
0.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$675.4K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCWC
HCWC
SGHT
SGHT
Q4 25
$-855.1K
$-1.8M
Q3 25
$-308.7K
$-8.7M
Q2 25
$1.1M
$-7.5M
Q1 25
$1.1M
$-11.6M
Q4 24
$-3.5M
Q3 24
$362.0K
Q2 24
$-9.5M
Q1 24
$-9.8M
Free Cash Flow
HCWC
HCWC
SGHT
SGHT
Q4 25
$-927.1K
$-2.0M
Q3 25
$-351.3K
$-8.9M
Q2 25
$988.6K
$-7.8M
Q1 25
$965.3K
Q4 24
$-3.6M
Q3 24
$311.0K
Q2 24
$-9.5M
Q1 24
$-9.9M
FCF Margin
HCWC
HCWC
SGHT
SGHT
Q4 25
-5.0%
-9.7%
Q3 25
-1.8%
-44.7%
Q2 25
4.9%
-39.6%
Q1 25
4.8%
Q4 24
-18.9%
Q3 24
1.5%
Q2 24
-44.7%
Q1 24
-51.4%
Capex Intensity
HCWC
HCWC
SGHT
SGHT
Q4 25
0.4%
0.8%
Q3 25
0.2%
0.9%
Q2 25
0.4%
1.1%
Q1 25
0.6%
0.0%
Q4 24
0.7%
Q3 24
0.3%
Q2 24
0.4%
Q1 24
0.6%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCWC
HCWC

Retail Grocery$17.1M91%
Food Service Restaurant$1.7M9%

SGHT
SGHT

Surgical Glaucoma$19.7M96%
Other$724.0K4%

Related Comparisons